Physician profile
Scott M Koerber
NPI 1013229863
$57,634.53
in general payments reported to CMS, 2019-2025
40 companies · $10K in 2025
The $10K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,899 · 2020: $1,464 · 2021: $5,211 · 2022: $12K · 2023: $18K · 2024: $6,218 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $8,671 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,975.00 |
| Food and Beverage | $8,671.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,930.31 | 2019-2025 | Ensite, Advisor, Tacticath Ablation Catheter, Sensor Enabled |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10,005.26 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $8,545.76 | 2019-2025 | Watchman Flx, Accolade Sr, Emblem Mri S-Icd |
| Biosense Webster, INC. | $7,993.75 | 2019-2025 | Carto 3, Qdot Micro, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $7,875.00 | 2023-2024 | Carto 3 |
| Biotronik INC. | $1,770.07 | 2019-2025 | Biomonitor, Amvia Edge |
| Medtronic, INC. | $900.27 | 2021-2025 | Linq II, Micra, Affera Mapping System |
| Medtronic Vascular, INC. | $876.13 | 2019-2020 | |
| Amgen INC. | $470.52 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $326.33 | 2019-2023 | |
| Cordis US Corp. | $315.89 | 2025 | Mynx Control Venous |
| Novartis Pharmaceuticals Corporation | $262.08 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $247.44 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $229.92 | 2021-2025 | Verquvo |
| Philips North America LLC | $202.29 | 2019-2024 | (Ao0) Igt Devices Intracardiac |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $194.61 | 2019-2023 | |
| Pfizer INC. | $186.18 | 2019-2025 | |
| Cardiva Medical, INC. | $184.44 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $125.08 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $112.03 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $104.36 | 2019-2025 | Camzyos |
| Irhythm Technologies, INC. | $91.64 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Vital Connect, INC | $65.10 | 2024-2025 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $64.71 | 2021-2023 | Opsumit |
| Kiniksa Pharmaceuticals International, Plc | $63.45 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.97 | 2019-2023 | Jardiance |
| Stereotaxis INC | $53.06 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $49.35 | 2024 | Evkeeza |
| Novo Nordisk INC | $47.31 | 2024 | Wegovy, Ozempic |
| Biobeat USA INC. | $44.73 | 2024 | Bb-613 Bpm Kit |
| Impulse Dynamics (USA) INC. | $39.29 | 2021-2025 | Optimizer, Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $30.97 | 2023 | Arcalyst |
| Recor Medical INC | $29.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Amarin Pharma, INC. | $28.23 | 2020-2021 | |
| Shockwave Medical, INC | $23.77 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $23.41 | 2023 | Inpefa |
| Catheter Precision INC. | $18.89 | 2024 | |
| Amryt Pharma Holdings LTD | $16.77 | 2021 | |
| Glaxosmithkline, LLC. | $16.25 | 2025 | Shingrix |
| Esperion Therapeutics, INC. | $14.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Koerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.